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Background: Gonococcal infection remains an important public health problem 
worldwide. The incidence of reported gonorrhoea cases in Sweden raised by 32%, 
from 5.9 to 7.8 cases per 100,000 in 2001 to 2008.The aim of this study is to 
estimate the lag time or time elapsed between onset of symptoms and diagnosis of 
gonorrhoea, and to identify the factors associated with diagnostic delay in a sample 
of reported gonorrhoea cases in Sweden. 
Methods: A retrospective cohort study was conducted using all reported 
gonorrhoea cases at the Swedish Institute for Communicable Disease Control (SMI) 
from the time period 1999-2009. Total number of cases included in final analysis 
was 2161. Descriptive statistics, ANOVA, independent t-test and multiple linear 
regression analysis were applied for data analysis.  
Results: The mean lag time between onset of symptoms and diagnosis of 
gonorrhoea was 12.3 ± 18.8 days. There was a significant association of lag time 
with sex, region, type of clinics and type of specimen and year of diagnosis. In 
multivariate analysis with adjusted model, type of specimen was found to have 
independent effect on lag time and there was a significant interaction observed 
between region and sex indicating difference between sexes was due to difference 
in regions. 
Conclusion: The result of our study revealed a significant delay in establishing a 
diagnosis in Gonorrhoea patient sample in Sweden. The variables influencing this 
delay in diagnosis should be addressed to shorten the lag time leading to an early 
diagnosis and a proper treatment in our patients. However, more research needs to 
be carried out in this area to better understand the factors at work. 
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Gonorrhoea is the second most common bacterial 
sexually transmitted infection caused by gram negative 
intracellular diplococci Neisseria gonorrhoeae. It has a 
major impact on health worldwide.1-3  
Incubation period of gonorrhoea varies from 2-30 days. 
Infection predominantly involves the columnar 
epithelium of the urethra, endocervix, rectum, pharynx 
and conjunctiva. Transmission usually occurred by 
genital- genital, genital- anorectal, oro-genital or oro-
anal contact or by mother-to-child transmission at birth. 
In women symptoms include increased or altered 
vaginal discharge, lower abdominal pain, intermenstrual 
bleeding, dysuria and menorrhagia. In men, the most 
common complaints are urethral discharge and painful 
urination (dysuria). Of infected women, 30 to 60 % 
remain asymptomatic or subclinical whereas only 5-10 
% of infected men will not develop symptoms. Rectal 
and pharyngeal infections are usually asymptomatic. 
Newborns exposed to infected secretions during birth 
develop eye infections known as opthalmia 
neonatorum. 4-5 
Untreated patients remain as carriers for several 
months leading to ascending and complicated infections 
and further spread of the disease into the population. 
Women may suffer from pelvic inflammatory disease, 
chronic pelvic pain, ectopic pregnancy, tubal infertility 
and adverse outcomes of pregnancy (spontaneous 
abortion, still birth, prematurity, and a low birth weight 
of neonate) while men may experience epididymitis, 
prostatitis and urethral stricture. 2,6 Occasionally, some 
individuals may also develop disseminated infections 
with systemic complications. 7-8 
Gonorrhoea infection has also been found to increase 
susceptibility and transmission of HIV infection.9-10
Several studies had reported a high proportion of HIV 
infection in patients with gonorrhoea which suggests 
that gonorrhoea diagnosis especially in MSM is an 
important risk marker for HIV.10  
Gonococcal antibiotic resistance has been increasing for 
two decades and recently treatment failure have been 
reported worldwide even with newer therapy such as 
azithromycin and extended- spectrum cephalosporins 
such as cefixime and ceftriaxone posing an ongoing 
INTRODUCTION 
problems for the management of individual patients 
and also at the public health level on disease control 
effort for gonorrhoea.11-13  
Globally about 95 million new cases of gonorrhoea were 
estimated among men and women.14 In Sweden there 
was a steady decline in gonorrhoea incidence during the 
1970s, 1980s and early 1990s. Similar epidemiological 
trends were also observed in many other high and 
middle income countries worldwide.15 After 1996, the 
gonorrhoea incidence in Sweden together with other 
European countries like Denmark, Norway began to rise 
again.16-18  Recent study in Sweden has reported about 
32 % increment in incidence of gonorrhoea cases over 
the last eight years (2001 to 2008). Among them up to 
86 % of the cases occurred in men with the highest 
proportion (41-59 %) in heterosexually infected men 
who acquired infection abroad, mainly in Thailand.19 
In contrast women and men who have sex with men 
(MSM) were found to acquire infection within Sweden. 
This re-emergence of gonorrhoea was primarily due to 
outbreaks among MSM, increased transmission among 
young heterosexuals of both sexes and resistance to 
antimicrobials like penicillin, tetracycline, 
fluoroquinolones used in the traditional treatment of 
the gonococcal infection.11,20 In addition adoption of 
more risky sexual behaviour for e.g. an increase in the 
number of sexual partners and the number of new/ 
casual sexual partners and / or low use of condoms in 
the Swedish population were also reported as the most 
likely reason for this recent increase in gonorrhoea 
cases.19 
Bearing in mind the increased infection rates, increasing 
prevalence of antibiotic resistance strains, increased 
susceptibility to and transmission of HIV infection, and 
serious complications of gonorrhoea infection, early 
diagnosis and effective treatment is essential for 
effective prevention and control of gonorrhoea.21 
Despite the considerable amount of information 
published on many different aspects of gonorrhoea, not 
a single study have evaluated the lag time or time which 
has elapsed between the onset of symptoms and 
diagnosis of  gonorrhoea. With better knowledge of lag
time / diagnosis delay efforts against gonorrhoea 
 Arpana  et, al. Time elapsed from onset of symptoms to diagnosis of Gonorrhoea AJMS 2014 Vol 5 Num 1  
 















































MATERIALS AND METHODS 
RESULTS 
prevention can be more effective.  
The aim of this was to estimate the lag time occurring 
between onset of symptoms and diagnosis of 
gonorrhoea and to identify the factors associated with 
lag time in a sample of registered gonorrhoea cases at 
the Swedish Institute for Communicable Disease 
Control (SMI) from the period 1999 to 2009.  
 
different subgroups 0-18, 19-30, 31-42 and >42 
respectively. 
Statistical analysis: 
First of all, descriptive statistics were carried out with 
mean, standard deviation, frequency, and percent 
distribution of each variable considered in our analysis. 
Because of the positive skew for lag time in days, the 
data were log transformed. Univariate association of lag 
time with each covariate was assessed using ANOVA 
and t-tests. Further we conducted multiple regression 
analysis with log lag time and significant covariates 
through backward elimination procedure. All the results 
are reported as mean ± SD unless stated otherwise. For 
all analyses, a two-tailed approach was used and a p-
value less than 0.05 was considered as the level of 
statistical significance. All statistical analyses were 
carried out using the statistical software “R- 2.10.1 for 
WINDOWS” (www.r-project.org). 
 
Description of study sample 
Out of 6555 patients only 2161 (32.9 %) with complete 
information on date of onset of symptoms and 
diagnosis of Gonorrhoea were included in our study.  
The majority of patients were males (92.2 %) and the 
mean age was 33.4 ± 10.9 (mean ± SD). 
The predominant age group was between 19- 30 years 
(43 %). Among males 43.4% were reported to acquire 
gonorrhoea through the contact with males and 55.8 % 
were reported to acquire gonorrhoea through the 
contact with females. Among female 9.5 % were 
reported to acquire gonorrhoea through the contact 
with females and 89.9% were reported to acquire 
gonorrhoea through the contact with males. Most of 
the patients in our study were from the central region 
(Svealand) of Sweden (65.9 %) and the majority of the 
cases were acquired from Europe (70.5 %). More than 
half of the cases (58.5%) were found to be infected in 
Sweden whereas only 38.5 % of cases got infection 
abroad. 
A majority of the patients were having acute symptoms 
(94.5 %) while presenting at clinic and the commonest
route of transmission was heterosexual (57.5 %) 
This is a retrospective, cohort (of patients) study based 
on data acquired from the Swedish national computer-
based surveillance system ‘SmiNet’ (www.sminet.se) 
which is maintained by Swedish Institute for 
Communicable Disease Control.  
In this study, we have included 2161 (32.9 %) cases out 
of 6555 registered cases at SmiNet in the period 
between January 1999 and December 2009. Inclusion 
was based on cases with complete information on date 
of onset of symptoms and date of diagnosis. We 
estimated lag time between date of onset of symptoms 
and date of gonorrhoea diagnosis reported by health-
care clinics. Further explanatory variables/ covariates 
were selected based on their potential influence on lag 
times to establish diagnosis.  
Covariates in our analysis were age, sex, reporting 
county of Sweden, route of transmission, diagnosis 
year, types of clinics, types of specimen, type of 
symptoms and probable continent of acquisition. We 
compiled reporting county in three different regions: 
Götaland (GL, southern part of Sweden); Svealand (SL, 
central part of Sweden) and Norrland (NL, northern 
part of Sweden). Similarly countries of acquisition were 
subdivided into six different continents, namely Asia, 
Africa, South America, North America, Europe and 
Oceania. We have also used this variable as domestic 
and abroad acquired cases. Types of clinics were 
subdivided into Sexually transmitted infection (STI), 
youth, gynaecological, private and other types of clinics 
respectively. Types of specimen were also further 
divided into cervical, rectal, urethral and other type of 
specimens. Types of symptoms were subdivided into 
acute symptoms, asymptomatic carrier and other 
symptoms categories. We categorised age into four 
  
 




















































followed by homosexual (40%) and perinatal (0.2 %). 
Among different types of specimen used for 
establishing Gonorrhoea diagnosis, urethral discharge 
was the most predominant (18.5 %) specimen in our 
study sample. 
Most of the patients were diagnosed in STI (Sexually 
transmitted infection) clinic which accounts for (20.3 %) 
as compared to youth clinics (1.2%), private (0.7%), 
gynaecology (0.7 %) and other types of clinics (12.7 %) 
respectively (Table.1). 
Univariate analysis of factors potentially influencing 
lag times to establish diagnosis and initiate treatment 
in patients with Gonorrhoea 
There was a significant relationship of lag time with sex, 
region, type of clinics, type of specimen and diagnosis 
years. But no significant association were detected with 
age, route of transmission, types of symptoms and 
probable continent of acquisition (Table 2).  
The mean lag time was significantly higher in women 
than men (16.4 ± 22.8, p< 0.01).  
Similarly the mean lag time was found to be longest in 
northern (13.5 ± 15.2) part of Sweden and shortest in 
southern region (10.8 ± 14.5). We found a significant 
difference (p < 0.00) in mean lag time between 
Northern (NL) and Southern (GL) as well as between 
Central (SL) and Southern (GL) regions of Sweden. 
Among different types of clinic, the youth clinic had the 
highest mean lag duration (15.5 ± 23.7) and STI clinic 
had the lowest mean lag time (9.4 ± 10.9). There was a 
significant difference in mean lag time between STI-
clinic and other types of clinic (p< 0.00).The mean lag 
time was highest in case of urethral specimen (14.4 ±
25.0) and lowest in rectal specimen (8.6 ± 12.3). There 
was a significant difference observed between urethral 
and rectal specimen (p< 0.03). The highest mean lag 
time was observed in the diagnosis year 2000 – 2004 
(13.6 ± 23.1). There was a significant difference in mean 
lag time between the diagnosis years 2000-2004 to 
2005-2009 (p < 0.01).  
Mean lag time was highest in age group 0-18 (15.1 ± 
20.7) and lowest in age group more than 42 years (11.8 
± 15.4). Mean lag time was highest with heterosexual  
route of transmission (12.4 ± 16.7) than homosexual 
(12.3 ± 21.9) and other route of transmission (7.4 ± 6.4). 
Similarly we found that mean lag time was higher in 
domestic cases (12.6 ± 21.3) as compared to cases 
acquired abroad (11.9± 12.0). Those patients who 
probably got infected in Oceania were found to have 
the longest mean lag time (16.8 ± 18.0) and cases  with 
probable acquisition in South America had shortest 
mean lag time (9.5 ± 6.8). However; these differences 
were not statistically significant (p >0.05) (Table 2). 
Multiple linear regression analyses of lag time with 
adjusted covariates 
In the final model, type of specimen had independent 
main effect on lag time between onset of symptoms 
and diagnosis of Gonorrhoea. In addition to it, there 
was a significant interaction observed between region 
and sex. We have found that difference between sexes 
is different in different region. In northern (NL) and 
central (SL) Sweden, women have longer lag time as 
compared to men where as in southern (GL) Sweden 
men have longer lag time than women (Table 3). 
The mean lag time for all patients included in our study 
was 12.3 ± 18.8 days which suggests a significant delay 
from symptoms onset to diagnosis. Further, we 
detected significant associations of sex, region, type of 
clinic, type of specimen and diagnosis year with lag 
time.  
To our knowledge, no single previous study has been 
carried out evaluating lag time between onset of 
symptoms and diagnosis of gonorrhoea. However there 
are several studies showing a relation of lag time in 
other diseases such as rheumatoid arthritis, 
endometriosis etc.22-23 Health care disparities, 
differences in medical care access, patients and 
physician’s lack of awareness of disease, choice of 
physician or clinic for first consultation, time to carry 
out diagnostic testing, referral to a relevant specialist, 
lack of uniform guidelines for diagnosis have been 
reported to be the cause of potential delay to establish 
a diagnosis and to initiate treatment in many 
countries.22 There might be other various reasons by  
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Table 1. Descriptive statistics of the sample (N= 2161) 
Attributes/ Variables N (%) 
Age (mean ± SD) 33.4 ± 10.9 
0-18 66 (3.0) 
19-30 931 (43.0) 
31-42 753 (34.8) 
>42 411 (19.0) 
Sex  
Male 1993 (92.2) 
Female 168 (7.8) 
Region  
NL (Norrland, North) 118(5.4) 
SL (Svealand, Central) 1425 (65.9) 
GL(Götaland, South) 618 (28.6) 
Year of diagnosis  
1999 - <2000 158 (7.3) 
2000-2004 1081 (50.0) 
2005-2009 922 (42.7) 
Lag time in days, mean ± SD  
Lag time between onset of symptoms and diagnosis of Gonorrhoea          12.3 ± 18.8 
Log lag time in days, mean ± SD 2.2 ± 0.8 
Probable continent of infection  
Asia  478 (22.1) 
Africa 47 (2.1) 
Europe 1524 (70.5) 
South America 12 (0.5) 
North America 26 (1.2) 
Oceania 7 (0.3) 
      Missing                67 (3.1) 
OR  
Origin of cases  
Sweden 1266 (58.5) 
Abroad 833 (38.5) 
Missing 62 (2.8) 
Type of Clinic  
Private 16 (0.74) 
STI 439 (20.31) 
Youth 26 (1.20) 
Gynae 16 (0.74) 
Other  276 (12.77) 
Missing 1388 (64.22) 
Type of Specimen  
Cervical 29 (1.3) 
Rectal 21 (0.9) 
Urethral 401 (18.5) 
Other 121 (5.6) 
Missing 1589 (23.5) 
Type of Symptom  
Acute Symptoms 2043 (94.5) 
Asymptomatic 9 (0.4) 
Other 77 (3.5) 
Missing 32 (1.4) 
Route of transmission  
Heterosexual 1243 (57.5) 
Homosexual 866 (40.0) 
Perinatal 6 (0.2) 
Other 10 (0.4) 
Missing 36 (1.6) 
  
 










Table 2. Univariate analysis of lag time with age, sex, region, year of diagnosis, probable continent of infection, type of clinic, type 
of specimen, type of symptoms and route of transmission.   
Lag time 
         Variable name / Categories        Mean ± SD P value 
                         Age (mean ± SD)  
0-18 15.10 ± 20.7 0.72 
19-30 12.16 ± 14.4 
31-42 12.67 ± 24.3 
>42 11.85 ± 15.4 
                                   Sex        
Male 16.43 ± 22.8 0.01* 
Female 12.03 ± 18.4 
                               Region  
NL (Norrland, North) 13.54 ± 15.2 0.00* 
SL (Svealand, Central) 12.92 ± 20.6 
GL(Götaland, South) 10.89 ± 14.5 
                      Year of diagnosis  
1999 - <2000 11.46± 12.5 0.01* 
2000-2004 13.69 ± 23.1 
2005-2009 10.98 ± 13.1 
        Probable continent of infection  
Asia 12.48 ± 11.8 0.18 
Africa 13.42± 11.5 
Europe 12.29 ± 20.1 
South America 9.58 ± 6.8 
North America 10.84 ± 8.1 
Oceania 16.85 ± 18.0 
                                  OR  
Origin of cases   
Sweden 12.64 ± 21.3 0.18 
Abroad 11.93 ± 12.06 
                       Type of Clinic   
Private 11.50 ± 3.28 0.00* 
STI 9.46  ± 10.9 
Youth 15.57 ± 23.7 
Gynae 12.25 ± 20.3 
Other 11.75 ± 13.1 
                      Type of Specimen   
Cervical 9.03 ± 8.0 0.03* 
Rectal 8.66 ± 12.3  
Urethral 14.48 ± 25.0  
Other 12.48 ± 16.6  
                    Type of Symptom 
Acute Symptoms 12.40 ± 19.2 0.25 
Asymptomatic 9.22 ± 12.9 
Other 12.79 ± 11.4 
                  Route of transmission 
Heterosexual 12.49 ± 16.7 0.11 
Homosexual 12.31 ± 21.9 
Perinatal 12.16 ± 5.07 
Other 7.40 ± 6.4 
* p<0.05 is considered as the level of statistical significant 
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Table 3. Final model of lag-time 
 Sum Sq Df F value Pr (>F) 
Region 8.34 2 5.66 0.00 ** 
Sex 2.93 1 3.97 0.04 * 
Type of specimen 7.68 3 3.47 0.01 * 
Region*Sex 4.93 2 3.34 0.03 * 
Residuals 414.86 563   
    * p<0.05 is considered as the level of statistical significant,       ** p<0.00   is considered as highly statistical significant 
 
which diagnosis may be delayed. Very often symptoms 
develop insidiously and patients may not seek medical 
care after several weeks or months of disease onset. It 
is also likely that the perception of people that it is a 
desirable character trait to delay seeking help for vague 
symptoms and wait until they are unquestionably ill. In 
reality subclinical and asymptomatic infection is not 
regarded by the patients as sufficiently serious to 
present to a hospital or clinic. Physicians might miss 
subclinical infection due to lack of awareness. In many 
European countries screening for rectal and pharyngeal 
infections which are often asymptomatic are not 
included in a routine screening, which might result in 
under-diagnosis of MSM in particular. 24-26    
We found that women in our study population had 
significantly higher lag time (16.43 ± 22.8 days) 
compared to men (12.03 ± 18.4 days). Some studies 
reported that the average incubation period for women 
was found to be somewhat longer as compared to male 
(ten days vs. 2-5 days). Women also reported to be 
asymptomatic at higher level then men:about 30 to 60 
% of infected women will remain asymptomatic or 
subclinical. However; only 5-10 % of infected men were 
found to be asymptomatic. Usually most of them have 
acute symptoms such as urethral discharge and painful 
urination. 5 
 Women has different testing behaviour and are more 
used to testing as a general screening including 
Chlamydia test during their routine check up in 
pregnancy and on visit to gynaecologists and birth 
control counselling, but they are not routinely tested 
for gonorrhoea which might be the cause of missing 
gonorrhoea cases in women. Tested men are more 
often targeted because of symptoms or through 
contact tracing. More cases of gonorrhoea are seen in  
men than women in Europe. Gonococcal infections in 
women may be under- diagnosed due to the use of 
suboptimal diagnostic methods which favour the 
definitive diagnosis of male gonococcal urethritis. 24, 27 
In our study sample majority of the patients were male 
and among them 43.4 % were reported to acquire 
infection through the contact with males. Gonorrhoea 
is often spread through homosexual contacts between 
men; therefore more men than women were diagnosed 
early because the risk groups for infection are 
predominantly men and they are targeted with 
screening programmes.7 In Europe including Sweden, 
Norway Denmark and England, MSM accounts for a 
disproportionately large burden of gonorrhoea in 
recent years due to increase unsafe sexual behaviour 
following the introduction of highly active antiretroviral 
therapies. 15, 19, 28  
Among different types of clinic, we have found that the 
mean lag time was longest in patients who presented at 
youth clinic and shortest in STI clinics. Usually in 
Sweden, youth clinic deals with younger age group (less 
than 23 yrs) and patients presented at this clinic are 
usually not routinely screened for gonorrhoea. This 
might be one of the reasons in prolonged lag time of 
gonorrhoea in youth clinics. Same reason could be 
applied in case of age-group since our result revealed 
that the youngest age group (0-18) had longest lag 
time. So general practitioners or physicians have to be 
aware of gonorrhoea and should not only perform 
diagnostic samples for Chlamydia alone in these clinics. 
In addition, timely referral of gonorrhoea cases to STI-
clinic is also important for early diagnosis and effective 
treatment. On the other hand STI clinic serve the 
population over 18 yrs old and patients presented there 
might be diagnosed earlier. Therefore mean lag time  
  
 



















































might be shortest in patients who presented at STI 
clinics. 
Similarly, we found that urethral specimen had longest 
lag time while cervical specimen had shortest lag time. 
This would have been influenced by the type of 
diagnostic methods used and time to carry out 
diagnostic testing for gonorrhoea. Microscopy or direct 
smear for Gram staining can be performed as soon as 
the specimen is collected and offers a rapid diagnosis 
within a short time period. However culture needs 
longer time comparatively for confirmatory 
identification and antimicrobial susceptibility testing of 
gonorrhoea.6 There might be other technical reasons 
responsible for increased lag time with urethral 
specimen. 
The mean lag time was found to be longest in the 
diagnosis year 2000-2004. We could not find any 
specific reason why the lag time was prolonged 
particularly in these years. However we can speculate 
that it is more likely due to introduction of new 
diagnostic tools in order to improve sensitivity and 
specificity. 
 
not consider some important factors like education, 
occupation, marital status, sexual behaviour, number of 
sexual partners,type of diagnostic methods used for 
gonorrhoea screening that might also be responsible 
for delayed diagnosis and prolonged lag time. 
Data quality in terms of data completeness varied for 
some variables (e.g. type of doctor or physicians first 
consulted, reported county of acquisition, type of 
clinics, type of specimen) and some conclusions need to 
be drawn with caution. 
In addition, the precise date of the onset of symptoms 
and the date that these symptoms were reported to a 
physician were totally dependent on the patients’ 
ability to remember facts that very often occurred a 
long time ago and this may not be absolutely accurate. 
Our study sample contained predominantly male 
patients which is likely to overestimate the effect.  
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CONCLUSION 
Our study revealed a significant delay in establishing a 
diagnosis in a sub-cohort of Gonorrhoea patients in 
Sweden. The variables influencing this delay in 
diagnosis should be addressed in order to shorten the 
lag time leading to an early diagnosis, treatment. 
Further these findings might help in preventing and 
control of gonococcal infection. 
The findings of our study should guide public health 
professionals and policy makers in planning an effective 
and targeted preventive and control strategies towards 
gonococcal infection. However, more research needs to 
be carried out in this area to better understand the 
factors responsible for delayed diagnosis of gonorrhoea 
in Sweden.  
Limitations of the study: 
First of all, only one third of the reported cases were 
included into analysis, which might underestimate or 
overestimate our results. 
Since our study was conducted retrospectively we could 
REFERENCES 
1. Nelson.K.E, Williams.C.F. Infectious Disease epidemiology, 
Theory and Practice. 2
nd
 edition, 2007. 
2. Schaechter. M, Engleberg. N.C, DiRita.V.J , Dermody.T.




3. CDC. Trends in Reportable Sexually Transmitted Diseases in 
the United States, 2007. Available from :  
http://www.cdc.gov/NCHHSTP/Newsroom/docs/STDTrendsF
actSheet.pdf 




5. Bignell C. 2009 European (IUSTI/WHO) Guideline on the 
Diagnosis and Treatment of Gonorrhoea in Adults. 
International Journal of STD & AIDS 2009; 20: 453–457. doi: 
10.1258/ijsa.2009.009160 
6. Ng L-K, Martin IE.The laboratory diagnosis of Neisseria 
gonorrhoeae. Can J Infect Dis Med Microbiol 2005; 16(1):15-
25. 
7. Read P, Abbott R , Pantelidis P, et al. Disseminated 
gonococcal infection in a homosexual man diagnosed by 
nucleic acid amplification testing from a skin lesion swab. Sex 
Transm Infect 2008; 84: 348-349. doi: 
10.1136/sti.2008.030817 
 Arpana  et, al. Time elapsed from onset of symptoms to diagnosis of Gonorrhoea AJMS 2014 Vol 5 Num 1  
 




8.  Kraus S, Luedecke G, Ludwig M, Weidner W.  Periurethral 
Abscess Formation due to Neisseria gonorrhoeae. Urol Int 
2004; 73:358–36. doi: 10.1159/000081600 
  9. Røttingen JA, Cameron DW, Garnett GP. A systematic review 
of the epidemiologic interactions between classic sexually 
transmitted diseases and HIV: how much really is known? Sex 
Transm Dis. 2001; 28:579-97. 
10.  Torian LV, Makki HA, Menzies IB, et al. High HIV 
seroprevalence associated with gonorrhea: New York City 
Department of Health, sexually transmitted disease clinics, 
1990–1997. AIDS 2000; 14:189–195.  
11. Workowski KA, Berman SM, Douglas JM Jr. Emerging 
antimicrobial resistance in Neisseria gonorrhoeae: urgent 
need to strengthen prevention strategies. Ann Intern Med. 
2008; 148(8):606-13. 
12. Tapsall, John W. Neisseria gonorrhoeae and emerging 
resistance to extended spectrum cephalosporins. Current 
Opinion in Infectious Diseases 2009; 22(1): 87-91. doi:  
10.1097/QCO.0b013e328320a836 
13. Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, et al. 
Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 
2007; 13(8):1275-7. 
14. Schmid G. World Health Organization (WHO) 2005 global 
estimates of the incidence and prevalence of sexually 
transmitted infections (STIs). 
15. Berglund T, Fredlund H, Giesecke J. Epidemiology of the 
reemergence of gonorrhea in Sweden. Sex Transm Dis. 2001; 
28(2):111-4. 
16. Fenton KA, Lowndes CM. Recent trends in the epidemiology 
of sexually transmitted infections in the European Union. Sex 
Transm Infect. 2004; 80(4):255-63. 
17. Jakopanec I, Borgen K, Aavitsland P. The epidemiology of 
gonorrhoea in Norway, 1993-2007: past victories, future 
challenges. BMC Infect Dis. 2009; 9:33. 
18. Johansen JD, Smith E. Gonorrhoea in Denmark: high incidence 
among HIV-infected men who have sex with men. Acta Derm 
Venereol. 2002; 82(5):365-8. 
19. Velicko I, Unemo M. Increase in reported gonorrhoea cases in 




20. Martin IM, Hoffman S, Ison CA; ESSTI Network. European 
Surveillance of Sexually Transmitted Infections (ESSTI): the 
first combined antimicrobial susceptibility data for Neisseria 
gonorrhoeae in Western Europe. J Antimicrob Chemother. 
2006; 58:587-93. 
21. Jakopanec I, Hassfjord JJ, Nilsen O, Larsen AL, Aavitsland P. A 
local outbreak of quinolone-resistant gonorrhoea in Norway. 




22. Rodríguez-Polanco E, Al Snih S, Kuo YF, Millán A, Rodríguez 
MA.Lag time between onset of symptoms and diagnosis in 
Venezuelan patients with rheumatoid arthritis. Rheumatol Int.2010.
doi: 10.1007/s00296-009-1358-9 
23. Arruda1 MS, Petta1 CA, AbraÄo MS and Benetti-Pinto CL. Time 
elapsed from onset of symptoms to diagnosis of endometriosis in a 
cohort study of Brazilian women. Human Reproduction.2003; 18:
756-759. doi: 10.1093/humrep/deg136 
24. Savage EJ, Hughes G, Ison C, Lowndes CM, the European 
Surveillance of Sexually Transmitted Infections (ESSTI) network. 
Syphilis and gonorrhoea in men who have sex with men: a European 
overview. Euro Surveill. 2009; 14(47):pii=19417. Available online: 
http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19417 
25. Kent CK, Chaw JK, Wong W, Liska S, Gibson S, Hubbard G, et al. 
Prevalence of rectal, urethral, and pharyngeal chlamydia and 
gonorrhea detected in 2 clinical settings among men who have sex 
with men: San Francisco, California, 2003. Clin Infect Dis. 2005; 
41(1):67-74. 
26. Morris SR, Klausner JD, Buchbinder SP, Wheeler SL, Koblin B, 
Coates T, et al. Prevalence and incidence of pharyngeal gonorrhea in 
a longitudinal sample of men who have sex with men: the EXPLORE 
study. Clin Infect Dis.2006; 43(10):1284-9. 
27. Naaber P, Uuskula A, Naaber J, Poder A, Hjelm E, Hallen A, et al. 
Laboratory diagnosis of sexually transmitted infections in Estonia in 
2001-2002: shortcomings with impact on diagnostic quality and 
surveillance. Sex Transm Dis. 2005; 32(12):759-64. 
28. Berglund T, Asikainen T, Tzmeier SG et al. The Epidemiology of 
Gonorrhea among Men Who Have Sex with Men in Stockholm, 
Sweden, 1990–2004. Sexually Transmitted Diseases.2007; 34:174–
179. doi: 10.1097/01.olq.0000230442.13532.c7 
 
Authors Contributions: 
AS: Concept and Design of the study, analysis and 
       interpretation, manuscript preparation, data      
       collection, statistical analysis, and literature  
       search. 
IV: Concept and Design of the study, analysis and 
       interpretation, manuscript preparation, 
       critical revision of the manuscript, statistical  
       analysis, and literature search. 
MK: Critical revision of the manuscript and   
         statistical analysis. 
MA: Critical revision of the manuscript. 
 
Conflict of Interest: Nil 
 
Date of Submission: 27.8.2013 
Date of Peer review: 29.8.2013 
Date of submission of final version: 30.8.2013 
Date of Acceptance: 30.8.2013 
Date of Publication: 9.9.2013 
 
 
 
